Abstract Submission Guidelines
- Abstracts should report an original work that has not been previously published or presented in other conferences.
- All abstracts will be published in the conference book.
Scientific abstracts of pediatric research related to the following topics are welcome:
- Neuromuscular disorders and peripheral neuropathies
- Neuroimmunology and neurological biomarkers
- Neurocutaneous disorders
- Seizure disorders/Status epilepticus/Neonatal seizures
- Movement disorders
- Paroxysmal disorders
- Neurocritical care
- Sleep disorders
- Cerebral palsy
- Neuroinfectious diseases including COVID-19
- Practice challenges in settings with limited resource
- Abstracts should have a maximum length of 250 words and be structured as follows:
- Title should be descriptive, direct, accurate, appropriate, interesting, concise, precise, unique, and should not be misleading. Do not use abbreviations.
- Authors’ names and their institutional affiliations. The name of the presenter should be underlined.
- Objective(s) should be clearly stated.
- Methods should contain sufficient details for an evaluation of the appropriateness and novelty
- Results should have sufficient details to support the conclusion. Any abstracts containing “results will be discussed” or “data will be presented” will not be accepted.
- 3 to 5 Keywords provided
- Font name and size: Times New Roman, size 12 points, 1.5 line spacing.
- Indent each paragraph with a tab space before beginning the text.
- Do not use underlining, bold, or capitalization for emphasis.
- Do not include tables, graphs or figures.
** Abstracts will be rejected if they do not comply with the above format. **
Instructions for abstract submission
- All abstracts must be submitted through the online abstract system. The applicant will receive an email acknowledging that the abstract has been successfully submitted.
- The following contact information is required for the presenting author: first name, last name, department, institution, street address, city, state/province, country, phone number and a valid e-mail address.
- Please note that further abstract modification is not allowed once the submission process is complete.
- The abstract will be peer reviewed by at least two competent reviewers to rate whether the abstract is qualified to be presented in the conference.
According to the deadline extension, there will be 2 steps of announcement.
- First announcement on 15 May 2023 (for the applicants who submitted the abstract before 30 Apr 2023), you will receive the notification whether the abstract is accepted, but the details about presenting platform will be further announced on 15 June 2023. If your abstract is accepted, we encourage the applicant to register as a delegate by 20 June 2023 to get an early bird registration fee rate.
- Second announcement on 15 June 2023, the applicant will receive the notification whether the abstract is accepted and in which of the following presentation categories
1) Oral platform presentation (present 8 minutes + Q&A 2 minutes)
2) Oral poster presentation (present 3 minutes + Q&A 2 minutes during the poster tour)
3) Poster presentation (no oral presentation is required)
(Note: Detailed instructions will also be provided via e-mail to the presenter)
The presenting author must register as a delegate to the conference after receiving notification for their abstract acceptance. The presenting author is responsible for all expenses incurred in the production of their presentations and for travel and accommodation during the conference. Please register as a delegate before 30 June 2023 to ensure that the abstract is published in the program book.
Abstract review criteria
- Relevance to the conference topics
- Significance of the scientific question(s) and results
- Clear question or hypothesis
- Sufficient background
- The experimental approach and rationale for the approach are clear
- The results are clearly presented
- The interpretation and conclusion are reasonable and logical